RE:Concerned about roll and upYeehaw1 wrote: ... only thing i am worried about that this roll up would land into buying something (like some minor companies) which could play a negative impact on the balance sheet as no one knows that how this is going to be occur in DM and if this involves buying of some other companies then could have impact.
i am not sure how this is going to work. If someone knows then please do share.
Seriously! Do you think Marshall and the team are going to walk into a company and say,
"We don't know what your company does in AI or how we could possibly integrate your AI tech into our business, but we want to buy you because we have $20 million and our business is going on an AI spending spree. Here's a blank cheque, please fill it out with how much you think we should pay you for your company, but don't go beyond $20 million because that's all we got at the moment and we have other companies to buy"
You know, I can't believe some of the stuff I read on here. I'm pretty confident Marshall and his team know what there are doing and will use the money to bring value to this company and grow it both financially and technologically. He was pretty clear about that in his interviews, but as usual most people don't actually listen to what he is saying. And then there's the soft bashers that like to pretend they are concerned about the company and look for anyway to throw in some fear where there really isn't any.
The only fear at the moment is the overall market and even that will eventually turn around. Meanwhile, no matter what the market does, DM will continue to grow. It won't effect the money in the bank or their balance sheet due to possible rising interest rates (no debt). DM covid testing will continue, so will their beta testing of MediCall, so will their AI contracts. In fact, looking around for AI companies while the market is down works in their favour. They can buy more for less. I'm just so glad the majority of the people on these bullboards don't run this company.